Skip to main content
SpringerLink
Log in

Macular Surgery

  • Chapter
  • First Online:
Vitreoretinal Disorders

Part of the book series: Current Practices in Ophthalmology ((CUPROP))

Abstract

The macula is a geographically small area of the retina that possesses immense anatomical and physiological significance, as well as high potential for the development of a variety of vitreomacular interface disorders. Many of these disorders are amenable to surgical correction. In this chapter, we describe surgical instrumentation and approaches to these disorders, nonsurgical alternatives, and emerging techniques in the field, with emphasis on epiretinal membranes, vitreomacular traction, and macular holes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Panozzo G, Parolini B, Gusson E, Mercanti A, Pinackatt S, Bertoldo G, et al. Diabetic macular edema: an OCT-based classification. Semin Ophthalmol. 2004;19(1–2):13–20.

    Article  CAS  PubMed  Google Scholar 

  2. Duker JS, Kaiser PK, Binder S, de Smet MD, Gaudric A, Reichel E, et al. The international vitreomacular traction study group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology. 2013;120(12):2611–9.

    Article  PubMed  Google Scholar 

  3. Recchia FM, Scott IU, Brown GC, Brown MM, Ho AC, Ip MS. Small-gauge pars plana vitrectomy: a report by the American Academy of Ophthalmology. Ophthalmology. 2010;117(9):1851–7.

    Article  PubMed  Google Scholar 

  4. Khan MA, Shahlaee A, Toussaint B, Hsu J, Sivalingam A, Dugel PU, et al. Outcomes of 27 gauge microincision vitrectomy surgery for posterior segment disease. Am J Ophthalmol. 2016;161:36–43. e1–2.

    Article  PubMed  Google Scholar 

  5. Mohamed S, Claes C, Tsang CW. Review of small gauge vitrectomy: progress and innovations. J Ophthalmol. 2017;2017:6285869.

    PubMed  PubMed Central  Google Scholar 

  6. Sakamoto T, Miyazaki M, Hisatomi T, Nakamura T, Ueno A, Itaya K, et al. Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown. Graefes Arch Clin Exp Ophthalmol. 2002;240(6):423–9.

    Article  PubMed  Google Scholar 

  7. Haritoglou C, Mauell S, Benoit M, Schumann RG, Henrich PB, Wolf A, et al. Vital dyes increase the rigidity of the internal limiting membrane. Eye. 2013;27(11):1308–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Badaro E, Novais EA, Penha FM, Maia M, Farah ME, Rodrigues EB. Vital dyes in ophthalmology: a chemical perspective. Curr Eye Res. 2014;39(7):649–58.

    Article  CAS  PubMed  Google Scholar 

  9. Gale JS, Proulx AA, Gonder JR, Mao AJ, Hutnik CM. Comparison of the in vitro toxicity of indocyanine green to that of trypan blue in human retinal pigment epithelium cell cultures. Am J Ophthalmol. 2004;138(1):64–9.

    Article  CAS  PubMed  Google Scholar 

  10. Kawahara S, Hata Y, Miura M, Kita T, Sengoku A, Nakao S, et al. Intracellular events in retinal glial cells exposed to ICG and BBG. Invest Ophthalmol Vis Sci. 2007;48(10):4426–32.

    Article  PubMed  Google Scholar 

  11. Hernandez F, Alpizar-Alvarez N, Wu L. Chromovitrectomy: an update. J Ophthalmic Vis Res. 2014;9(2):251–9.

    PubMed  PubMed Central  Google Scholar 

  12. Jackson TL, Vote B, Knight BC, El-Amir A, Stanford MR, Marshall J. Safety testing of infracyanine green using retinal pigment epithelium and glial cell cultures. Invest Ophthalmol Vis Sci. 2004;45(10):3697–703.

    Article  PubMed  Google Scholar 

  13. Balaiya S, Brar VS, Murthy RK, Chalam KV. Comparative in vitro safety analysis of dyes for chromovitrectomy: indocyanine green, brilliant blue green, bromophenol blue, and infracyanine green. Retina. 2011;31(6):1128–36.

    Article  CAS  PubMed  Google Scholar 

  14. Stalmans P, Feron EJ, Parys-Van Ginderdeuren R, Van Lommel A, Melles GR, Veckeneer M. Double vital staining using trypan blue and infracyanine green in macular pucker surgery. Br J Ophthalmol. 2003;87(6):713–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Almeida FP, De Lucca AC, Scott IU, Jorge R, Messias A. Accidental subretinal brilliant blue G migration during internal limiting membrane peeling surgery. JAMA Ophthalmol. 2015;133(1):85–8.

    Article  PubMed  Google Scholar 

  16. Malerbi FK, Maia M, Farah ME, Rodrigues EB. Subretinal brilliant blue G migration during internal limiting membrane peeling. Br J Ophthalmol. 2009;93(12):1687.

    PubMed  CAS  Google Scholar 

  17. Smiddy WE, Maguire AM, Green WR, Michels RG, de la Cruz Z, Enger C, et al. Idiopathic epiretinal membranes. Ultrastructural characteristics and clinicopathologic correlation. Ophthalmology. 1989;96(6):811–20; discussion 21.

    Article  CAS  PubMed  Google Scholar 

  18. Mori K, Gehlbach PL, Sano A, Deguchi T, Yoneya S. Comparison of epiretinal membranes of differing pathogenesis using optical coherence tomography. Retina. 2004;24(1):57–62.

    Article  PubMed  Google Scholar 

  19. Meuer SM, Myers CE, Klein BE, Swift MK, Huang Y, Gangaputra S, et al. The epidemiology of vitreoretinal interface abnormalities as detected by spectral-domain optical coherence tomography: the beaver dam eye study. Ophthalmology. 2015;122(4):787–95.

    Article  PubMed  Google Scholar 

  20. Klein R, Klein BE, Wang Q, Moss SE. The epidemiology of epiretinal membranes. Trans Am Ophthalmol Soc. 1994;92:403–25; discussion 25–30.

    PubMed  PubMed Central  CAS  Google Scholar 

  21. Kawasaki R, Wang JJ, Mitchell P, Aung T, Saw SM, Wong TY, et al. Racial difference in the prevalence of epiretinal membrane between Caucasians and Asians. Br J Ophthalmol. 2008;92(10):1320–4.

    Article  CAS  PubMed  Google Scholar 

  22. Mitchell P, Smith W, Chey T, Wang JJ, Chang A. Prevalence and associations of epiretinal membranes. The Blue Mountains Eye Study, Australia. Ophthalmology. 1997;104(6):1033–40.

    Article  CAS  PubMed  Google Scholar 

  23. Fong CS, Mitchell P, Rochtchina E, Hong T, de Loryn T, Wang JJ. Incidence and progression of epiretinal membranes in eyes after cataract surgery. Am J Ophthalmol. 2013;156(2):312–8. e1.

    Article  PubMed  Google Scholar 

  24. Miyazaki M, Nakamura H, Kubo M, Kiyohara Y, Iida M, Ishibashi T, et al. Prevalence and risk factors for epiretinal membranes in a Japanese population: the Hisayama study. Graefes Arch Clin Exp Ophthalmol. 2003;241(8):642–6.

    Article  PubMed  Google Scholar 

  25. Ng CH, Cheung N, Wang JJ, Islam AF, Kawasaki R, Meuer SM, et al. Prevalence and risk factors for epiretinal membranes in a multi-ethnic United States population. Ophthalmology. 2011;118(4):694–9.

    Article  PubMed  Google Scholar 

  26. Koh V, Cheung CY, Wong WL, Cheung CM, Wang JJ, Mitchell P, et al. Prevalence and risk factors of epiretinal membrane in Asian Indians. Invest Ophthalmol Vis Sci. 2012;53(2):1018–22.

    Article  PubMed  Google Scholar 

  27. Fraser-Bell S, Guzowski M, Rochtchina E, Wang JJ, Mitchell P. Five-year cumulative incidence and progression of epiretinal membranes: the Blue Mountains Eye Study. Ophthalmology. 2003;110(1):34–40.

    Article  PubMed  Google Scholar 

  28. Kunikata H, Abe T, Kinukawa J, Nishida K. Preoperative factors predictive of postoperative decimal visual acuity ≥1.0 following surgical treatment for idiopathic epiretinal membrane. Clin Ophthalmol. 2011;5:147–54.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Scheerlinck LM, van der Valk R, van Leeuwen R. Predictive factors for postoperative visual acuity in idiopathic epiretinal membrane: a systematic review. Acta Ophthalmol. 2015;93(3):203–12.

    Article  PubMed  Google Scholar 

  30. Machemer R. The surgical removal of epiretinal macular membranes (macular puckers) (author’s transl). Klinis Monatsblat Augenheilkun. 1978;173(1):36–42.

    CAS  Google Scholar 

  31. Reibaldi M, Longo A, Avitabile T, Bonfiglio V, Toro MD, Russo A, et al. Transconjunctival nonvitrectomizing vitreous surgery versus 25-gauge vitrectomy in patients with epiretinal membrane: a prospective randomized study. Retina. 2015;35(5):873–9.

    Article  PubMed  Google Scholar 

  32. Wong JG, Sachdev N, Beaumont PE, Chang AA. Visual outcomes following vitrectomy and peeling of epiretinal membrane. Clin Exp Ophthalmol. 2005;33(4):373–8.

    Article  PubMed  Google Scholar 

  33. Lehpamer BP, Carvounis PE. Pars plana vitrectomy for symptomatic epiretinal membranes in eyes with 20/50 or better preoperative visual acuity. Retina. 2015;35(9):1822–7.

    Article  PubMed  Google Scholar 

  34. Tranos P, Koukoula S, Charteris DG, Perganda G, Vakalis A, Asteriadis S, et al. The role of internal limiting membrane peeling in epiretinal membrane surgery: a randomised controlled trial. Br J Ophthalmol. 2017;101(6):719–24.

    Article  PubMed  Google Scholar 

  35. Semeraro F, Morescalchi F, Duse S, Gambicorti E, Russo A, Costagliola C. Current trends about inner limiting membrane peeling in surgery for Epiretinal membranes. J Ophthalmol. 2015;2015:671905.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Schechet SA, DeVience E, Thompson JT. The effect of internal limiting membrane peeling on idiopathic Epiretinal membrane surgery, with a review of the literature. Retina. 2017;37(5):873–80.

    Article  PubMed  Google Scholar 

  37. Steel DH, Lotery AJ. Idiopathic vitreomacular traction and macular hole: a comprehensive review of pathophysiology, diagnosis, and treatment. Eye. 2013;27(Suppl 1):S1–21.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Tzu JH, John VJ, Flynn HW Jr, Smiddy WE, Jackson JR, Isernhagen BA, et al. Clinical course of vitreomacular traction managed initially by observation. Ophthalm Surg Laser Imag Retina. 2015;46(5):571–6.

    Article  Google Scholar 

  39. John VJ, Flynn HW Jr, Smiddy WE, Carver A, Leonard R, Tabandeh H, et al. Clinical course of vitreomacular adhesion managed by initial observation. Retina. 2014;34(3):442–6.

    Article  PubMed  Google Scholar 

  40. Jackson TL, Nicod E, Angelis A, Grimaccia F, Prevost AT, Simpson AR, et al. Pars plana vitrectomy for vitreomacular traction syndrome: a systematic review and metaanalysis of safety and efficacy. Retina. 2013;33(10):2012–7.

    Article  PubMed  Google Scholar 

  41. Gonzalez MA, Flynn HW Jr, Bokman CM, Feuer W, Smiddy WE. Outcomes of pars plana vitrectomy for patients with vitreomacular traction. Ophthalm Surg Laser Imag Retina. 2015;46(7):708–14.

    Article  Google Scholar 

  42. Sonmez K, Capone A Jr, Trese MT, Williams GA. Vitreomacular traction syndrome: impact of anatomical configuration on anatomical and visual outcomes. Retina. 2008;28(9):1207–14.

    Article  PubMed  Google Scholar 

  43. Chan CK, Wessels IF, Friedrichsen EJ. Treatment of idiopathic macular holes by induced posterior vitreous detachment. Ophthalmology. 1995;102(5):757–67.

    Article  CAS  PubMed  Google Scholar 

  44. Rodrigues IA, Stangos AN, McHugh DA, Jackson TL. Intravitreal injection of expansile perfluoropropane (c(3)f(8)) for the treatment of vitreomacular traction. Am J Ophthalmol. 2013;155(2):270–6. e2.

    Article  CAS  PubMed  Google Scholar 

  45. Steinle NC, Dhoot DS, Quezada Ruiz C, Castellarin AA, Pieramici DJ, See RF, et al. Treatment of vitreomacular traction with intravitreal perfluoropropane (C3f8) injection. Retina. 2017;37(4):643–50.

    Article  CAS  PubMed  Google Scholar 

  46. Stalmans P, Benz MS, Gandorfer A, Kampik A, Girach A, Pakola S, et al. Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. N Engl J Med. 2012;367(7):606–15.

    Article  CAS  PubMed  Google Scholar 

  47. Stalmans P, Delaey C, de Smet MD, van Dijkman E, Pakola S. Intravitreal injection of microplasmin for treatment of vitreomacular adhesion: results of a prospective, randomized, sham-controlled phase II trial (the MIVI-IIT trial). Retina. 2010;30(7):1122–7.

    Article  PubMed  Google Scholar 

  48. Haller JA, Stalmans P, Benz MS, Gandorfer A, Pakola SJ, Girach A, et al. Efficacy of intravitreal ocriplasmin for treatment of vitreomacular adhesion: subgroup analyses from two randomized trials. Ophthalmology. 2015;122(1):117–22.

    Article  PubMed  Google Scholar 

  49. Dugel PU, Tolentino M, Feiner L, Kozma P, Leroy A. Results of the 2-year ocriplasmin for treatment for symptomatic vitreomacular adhesion including macular hole (OASIS) randomized trial. Ophthalmology. 2016;123(10):2232–47.

    Article  PubMed  Google Scholar 

  50. Fahim AT, Khan NW, Johnson MW. Acute panretinal structural and functional abnormalities after intravitreous ocriplasmin injection. JAMA Ophthalmol. 2014;132(4):484–6.

    Article  CAS  PubMed  Google Scholar 

  51. Tibbetts MD, Reichel E, Witkin AJ. Vision loss after intravitreal ocriplasmin: correlation of spectral-domain optical coherence tomography and electroretinography. JAMA Ophthalmol. 2014;132(4):487–90.

    Article  PubMed  Google Scholar 

  52. Hahn P, Chung MM, Flynn HW Jr, Huang SS, Kim JE, Mahmoud TH, et al. Safety profile of ocriplasmin for symptomatic vitreomacular adhesion: a comprehensive analysis of premarketing and postmarketing experiences. Retina. 2015;35(6):1128–34.

    Article  CAS  PubMed  Google Scholar 

  53. Flynn HW Jr, Relhan N. The Charles Schepens lecture: management options for vitreomacular traction: use an individualized approach. Ophthalmol Retina. 2017;1(1):3–7.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Kelly NE, Wendel RT. Vitreous surgery for idiopathic macular holes. Results of a pilot study. Arch Ophthalmol. 1991;109(5):654–9.

    Article  CAS  PubMed  Google Scholar 

  55. Spiteri Cornish K, Lois N, Scott N, Burr J, Cook J, Boachie C, et al. Vitrectomy with internal limiting membrane (ILM) peeling versus vitrectomy with no peeling for idiopathic full-thickness macular hole (FTMH). Cochrane Database Syst Rev. 2013;05(6):CD009306.

    Google Scholar 

  56. Spiteri Cornish K, Lois N, Scott NW, Burr J, Cook J, Boachie C, et al. Vitrectomy with internal limiting membrane peeling versus no peeling for idiopathic full-thickness macular hole. Ophthalmology. 2014;121(3):649–55.

    Article  PubMed  Google Scholar 

  57. Morescalchi F, Costagliola C, Gambicorti E, Duse S, Romano MR, Semeraro F. Controversies over the role of internal limiting membrane peeling during vitrectomy in macular hole surgery. Surv Ophthalmol. 2017;62(1):58–69.

    Article  PubMed  Google Scholar 

  58. Essex RW, Kingston ZS, Moreno-Betancur M, Shadbolt B, Hunyor AP, Campbell WG, et al. The effect of postoperative face-down positioning and of long- versus short-acting gas in macular hole surgery: results of a registry-based study. Ophthalmology. 2016;123(5):1129–36.

    Article  PubMed  Google Scholar 

  59. Hu Z, Xie P, Ding Y, Zheng X, Yuan D, Liu Q. Face-down or no face-down posturing following macular hole surgery: a meta-analysis. Acta Ophthalmol. 2016;94(4):326–33.

    Article  PubMed  Google Scholar 

  60. Iezzi R, Kapoor KG. No face-down positioning and broad internal limiting membrane peeling in the surgical repair of idiopathic macular holes. Ophthalmology. 2013;120(10):1998–2003.

    Article  PubMed  Google Scholar 

  61. Gottlieb CC, Martin JA. Phacovitrectomy with internal limiting membrane peeling for idiopathic macular hole. Can J Ophthalmol. 2002;37(5):277–82; discussion 82.

    Article  PubMed  Google Scholar 

  62. Kauffmann Y, Ramel JC, Isaico R, De Lazzer A, Bron AM, Creuzot-Garcher C. Long-term anatomical and functional outcomes after combined cataract and idiopathic epiretinal membrane surgery. Ophthalmic Res. 2017;57(2):125–34.

    Article  PubMed  Google Scholar 

  63. Kotecha AV, Sinclair SH, Gupta AK, Tipperman R. Pars plana vitrectomy for macular holes combined with cataract extraction and lens implantation. Ophthalmic Surg Lasers. 2000;31(5):387–93.

    PubMed  CAS  Google Scholar 

  64. Lahey JM, Francis RR, Fong DS, Kearney JJ, Tanaka S. Combining phacoemulsification with vitrectomy for treatment of macular holes. Br J Ophthalmol. 2002;86(8):876–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Simcock PR, Scalia S. Phaco-vitrectomy for full-thickness macular holes. Acta Ophthalmol Scand. 2000;78(6):684–6.

    Article  CAS  PubMed  Google Scholar 

  66. Theocharis IP, Alexandridou A, Gili NJ, Tomic Z. Combined phacoemulsification and pars plana vitrectomy for macular hole treatment. Acta Ophthalmol Scand. 2005;83(2):172–5.

    Article  PubMed  Google Scholar 

  67. Yiu G, Marra KV, Wagley S, Krishnan S, Sandhu H, Kovacs K, et al. Surgical outcomes after epiretinal membrane peeling combined with cataract surgery. Br J Ophthalmol. 2013;97(9):1197–201.

    Article  PubMed  Google Scholar 

  68. Kauffmann Y, Ramel JC, Lefebvre A, Isaico R, De Lazzer A, Bonnabel A, et al. Preoperative prognostic factors and predictive score in patients operated on for combined cataract and idiopathic epiretinal membrane. Am J Ophthalmol. 2015;160(1):185–92. e5.

    Article  PubMed  Google Scholar 

  69. Michalewska Z, Michalewski J, Dulczewska-Cichecka K, Nawrocki J. Inverted internal limiting membrane flap technique for surgical repair of myopic macular holes. Retina. 2014;34(4):664–9.

    Article  PubMed  Google Scholar 

  70. Michalewska Z, Michalewski J, Adelman RA, Nawrocki J. Inverted internal limiting membrane flap technique for large macular holes. Ophthalmology. 2010;117(10):2018–25.

    Article  PubMed  Google Scholar 

  71. Grewal DS, Fine HF, Mahmoud TH. Management of challenging macular holes: current concepts and new surgical techniques. Ophthalm Surg Laser Imag Retina. 2016;47(6):508–13.

    Article  Google Scholar 

  72. Michalewska Z, Michalewski J, Dulczewska-Cichecka K, Adelman RA, Nawrocki J. Temporal inverted internal limiting membrane flap technique versus classic inverted internal limiting membrane flap technique: a comparative study. Retina. 2015;35(9):1844–50.

    Article  PubMed  Google Scholar 

  73. Chen SN, Yang CM. Lens capsular flap transplantation in the management of refractory macular hole from multiple etiologies. Retina. 2016;36(1):163–70.

    Article  PubMed  Google Scholar 

  74. Grewal DS, Mahmoud TH. Autologous neurosensory retinal free flap for closure of refractory myopic macular holes. JAMA Ophthalmol. 2016;134(2):229–30.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Columbia University Medical Center, New York, NY, USA

    Aliaa H. Abdelhakim & Royce W. S. Chen

Authors
  1. Aliaa H. Abdelhakim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Royce W. S. Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Royce W. S. Chen .

Editor information

Editors and Affiliations

  1. University of California, Sacramento, California, USA

    Glenn Yiu

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Abdelhakim, A.H., Chen, R.W.S. (2018). Macular Surgery. In: Yiu, G. (eds) Vitreoretinal Disorders. Current Practices in Ophthalmology. Springer, Singapore. https://doi.org/10.1007/978-981-10-8545-1_8

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-8545-1_8

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-8544-4

  • Online ISBN: 978-981-10-8545-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation